These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34848794)

  • 41. Interferons and systemic lupus erythematosus: Pathogenesis, clinical features, and treatments in interferon-driven disease.
    Tanaka Y; Kusuda M; Yamaguchi Y
    Mod Rheumatol; 2023 Aug; 33(5):857-867. PubMed ID: 36440704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
    Braunstein I; Klein R; Okawa J; Werth VP
    Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenetics of systemic lupus erythematosus: A comprehensive review.
    Ghodke-Puranik Y; Niewold TB
    J Autoimmun; 2015 Nov; 64():125-36. PubMed ID: 26324017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.
    Tang Y; Luo X; Cui H; Ni X; Yuan M; Guo Y; Huang X; Zhou H; de Vries N; Tak PP; Chen S; Shen N
    Arthritis Rheum; 2009 Apr; 60(4):1065-75. PubMed ID: 19333922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis.
    Matta B; Barnes BJ
    Cytokine; 2020 Aug; 132():154731. PubMed ID: 31130331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. B Cell Tetherin: A Flow Cytometric Cell-Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus.
    El-Sherbiny YM; Md Yusof MY; Psarras A; Hensor EMA; Kabba KZ; Dutton K; Mohamed AAA; Elewaut D; McGonagle D; Tooze R; Doody G; Wittmann M; Emery P; Vital EM
    Arthritis Rheumatol; 2020 May; 72(5):769-779. PubMed ID: 31804007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity.
    Baechler EC; Bauer JW; Slattery CA; Ortmann WA; Espe KJ; Novitzke J; Ytterberg SR; Gregersen PK; Behrens TW; Reed AM
    Mol Med; 2007; 13(1-2):59-68. PubMed ID: 17515957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus.
    Kamiyama R; Yoshimi R; Takeno M; Iribe Y; Tsukahara T; Kishimoto D; Kunishita Y; Sugiyama Y; Tsuchida N; Nakano H; Minegishi K; Tamura M; Asami Y; Kirino Y; Ishigatsubo Y; Ozato K; Nakajima H
    Mod Rheumatol; 2018 Nov; 28(6):993-1003. PubMed ID: 29385873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferons in Systemic Lupus Erythematosus.
    Sirobhushanam S; Lazar S; Kahlenberg JM
    Rheum Dis Clin North Am; 2021 Aug; 47(3):297-315. PubMed ID: 34215365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Peripheral blood mRNA and interferon gene expression in systemic lupus erythematosus].
    Tang JP; Gu YY; Shen N; Qian J; Chen XX; Huang XF; Huang XY; Liang D; Guo Q; Yang CD; Bao CD; Chen SL
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):106-10. PubMed ID: 15840221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential role of RhoA GTPase regulation in type interferon signaling in systemic lupus erythematosus.
    Fan W; Wei B; Chen X; Zhang Y; Xiao P; Li K; Zhang YQ; Huang J; Leng L; Bucala R
    Arthritis Res Ther; 2024 Jan; 26(1):31. PubMed ID: 38243295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus.
    Casey KA; Smith MA; Sinibaldi D; Seto NL; Playford MP; Wang X; Carlucci PM; Wang L; Illei G; Yu B; Wang S; Remaley AT; Mehta NN; Kaplan MJ; White WI
    Arthritis Rheumatol; 2021 Mar; 73(3):459-471. PubMed ID: 32909675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of interferons (IFNs) in the differentiation of T peripheral helper (Tph) cells.
    Tanemura S; Seki N; Tsujimoto H; Saito S; Kikuchi J; Sugahara K; Yoshimoto K; Suzuki K; Kaneko Y; Chiba K; Takeuchi T
    Int Immunol; 2022 Sep; 34(10):533-544. PubMed ID: 35780437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis.
    Huard C; Gullà SV; Bennett DV; Coyle AJ; Vleugels RA; Greenberg SA
    Br J Dermatol; 2017 May; 176(5):1224-1230. PubMed ID: 27564228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of PSMB9 upregulated by interferon signature in the pathophysiology of cutaneous lesions of dermatomyositis and systemic lupus erythematosus.
    Nakamura K; Jinnin M; Kudo H; Inoue K; Nakayama W; Honda N; Kajihara I; Masuguchi S; Fukushima S; Ihn H
    Br J Dermatol; 2016 May; 174(5):1030-41. PubMed ID: 26713607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
    Front Immunol; 2018; 9():3085. PubMed ID: 30666255
    [No Abstract]   [Full Text] [Related]  

  • 57. IFN-α: A key therapeutic target for multiple autoimmune rheumatic diseases.
    De Ceuninck F; Duguet F; Aussy A; Laigle L; Moingeon P
    Drug Discov Today; 2021 Oct; 26(10):2465-2473. PubMed ID: 34224903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases.
    Jiang J; Zhao M; Chang C; Wu H; Lu Q
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):248-272. PubMed ID: 32557263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel type I IFN-producing cell subset in murine lupus.
    Lee PY; Weinstein JS; Nacionales DC; Scumpia PO; Li Y; Butfiloski E; van Rooijen N; Moldawer L; Satoh M; Reeves WH
    J Immunol; 2008 Apr; 180(7):5101-8. PubMed ID: 18354236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases.
    Wong D; Kea B; Pesich R; Higgs BW; Zhu W; Brown P; Yao Y; Fiorentino D
    PLoS One; 2012; 7(1):e29161. PubMed ID: 22235269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.